Using machine learning, an electronic nose can "smell" early signs of ovarian cancer in the blood. The method is precise and, ...

A blood sample does not have an obvious odor to a person in a lab coat. But to an electronic nose, it can carry a chemical signature that points toward disease.

What are the benefits and challenges of using multiomics approaches to discover cancer biomarkers? Multiomics means that scientists are measuring more than one class of analyte, such as DNA, RNA, or ...

ClearNote Health's enhanced Avantect Pancreatic Cancer Test features industry-leading detection sensitivity and specificity ...

Researchers have developed an electronic nose that can “smell” early signs of ovarian cancer in the blood. The method is precise and could eventually be used to find many different cancers.

Insulin resistance - when the body doesn't properly respond to insulin, a hormone that helps control blood glucose levels - ...

We trained and tested ML systems that predict a deterioration in nine patient-reported symptoms within 30 days after treatments for aerodigestive cancers, using internal electronic health record (EHR) ...

A total of 590 patients were identified, 432 in the development set and 158 in the validation set. The median age was 51 years, and 55.8% (329 of 590) experienced grade 3 or 4 toxicity. The ...

A powerful artificial intelligence (AI) tool could give clinicians a head start in identifying life-threatening complications ...

Startup SpotitEarly is pioneering an innovative early cancer screening test based on breath samples and powered by artificial intelligence and the strong scent detection of trained dogs. SpotitEarly ...